ARCHIVES

ODAC Reviews Post-Marketing Studies for Eight Indications

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

DCPC Advisor O Trial Of Cervical Lesion Management With HPV

June 3, 1994

DeVita Swearing In Schedule Aug. 8

August 1, 1980

In Brief: Let Salaries Rise To Legal Levels, Biomedical Panel Says; Prostatic Cancer Blood Test Found

July 9, 1976

Lombardi Cancer Center, UDC Collaborate to Increase Cancer Awareness Among Blacks

August 3, 2001

NIAID Advisors Ok Recompetition of Pediatric ACTGs

February 14, 1992